Mercedes Machuca Ostos

I have joined both the Lotje Zuur group and the Daniela Thommen group in August 2020, to focus on the translational research linked to clinical trials.

We aim to find biomarkers of response to immunotherapy and the mechanisms behind this response, for an improved prediction of the outcome and better treatment decision for cancer patients.